Literature DB >> 11214790

Candesartan and acute liver injury.

D González-Jiménez1, J M Varela, E Calderón, J Galindo, M A González de la Puente.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11214790     DOI： 10.1007/s002280000220

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN： 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  2 in total

Review 1.  Noncholestatic acute hepatocellular injury following candesartan administration.

Authors:  Jan Antonio Lammel-Lindemann; Eduardo Flores-Villalba; Alexandro Jose Martagón; Eduardo DeObeso-Gonzalez; Francisco Puente-Gallegos
Journal:  Br J Clin Pharmacol       Date:  2017-10-22       Impact factor: 4.335

2.  Fimasartan-induced liver injury in a patient with no adverse reactions on other types of angiotensin II receptor blockers: A case report.

Authors:  Dae Hwa Park; Gee Young Yun; Hyuk Soo Eun; Jong Seok Joo; Ju Seok Kim; Sun Hyung Kang; Hee Seok Moon; Eaum Seok Lee; Byung Seok Lee; Kyung Hee Kim; Seok Hyun Kim
Journal:  Medicine (Baltimore)       Date:  2017-11       Impact factor: 1.817
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.